Momenta Pharmaceuticals, Inc. (MNTA)

[Boing x 2]

pollyvonwog,

I agree. It is hard to up the price once one decreases the price. I will not be upset for MNTA to cover all expenses for each quarter to knock out a new drug each quarter without dipping into the cash.

The patients will all benefit on new drugs in the long run. IVIg being a major one.

I am sure the price will come down with time.

They likely are taking advantage of sole drug pricing while they can. I agree they want the 3x priced right when it is approved.

One has to look at the fact that we are not even to the end of our first quarter selling the new drug. Will I be upset if we are at 52K annual scripts at the end of the first full quarter and growing? NO WAY!

What will the script numbers be at the end of the 4th quarter with United Healthcare and others on board starting in September?

Boing X 2